Real-time enrollment status for this borderline resectable/unresectable pancreatic cancer clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 8:45 AM UTC
| NCT Number | NCT07539155 |
| Recruiting Status | Recruiting |
| Condition | Borderline Resectable/Unresectable Pancreatic Cancer |
| Phase | PHASE1 |
| Target Enrollment | 20 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Arkansas |
| Last Updated on CT.gov | September 1, 2026 (Yesterday) |
As of September 2, 2026: Clinical trial NCT07539155 is currently recruiting participants. This phase1 study for borderline resectable/unresectable pancreatic cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Arkansas. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07539155 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07539155 was last updated Yesterday (September 1, 2026). HelloStudys verifies this status automatically.